Cancer/Tumor Profiling Market 2019 by Key Players Analysis, Share, Growth Drivers, Demand and Forecast by 2023 - P&S Intelligence

The cancer/tumor profiling market in terms of technology has been segmented into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology. NGS held the largest share in the cancer/tumor profiling industry, standing at 33.1%, in 2016. This leading position of NGS is mainly characterized by increased awareness about NGS products due to rising promotional activities for these products among the research laboratories and academic institutes. The NGS category is also expected to grow at the highest CAGR during the forecast period.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample

Europe held the second largest share of 27.7% in the global cancer/tumor profiling market in 2016. The growth in the European market for cancer/tumor profiling is mainly led by growing aging population, increasing prevalence of chronic pain, and neurological disorders and R&D infrastructure. By 2023, the European market for cancer/tumor profiling is expected to cross $23.0 billion dollar, growing at a CAGR of 18.5% between 2017-2023. Among all the European countries, Germany held the largest share in the European cancer/tumor profiling industry and is expected to register a CAGR of 19.3% in the forecast period.

The key players in the cancer/tumor profiling market are collaborating with other firms to expand their market share. In September 2017, Indivumed, GmbH and Helomics Corp. entered into a partnership to analyze human cancer biospecimens and annotated clinical data from consenting patients around the world.

Explore Report at: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market

Some of the other key players operating in the cancer/tumor profiling market include Illumina, Inc., NeoGenomics Inc., Caris Life Sciences, Inc., Oxford Gene Technology, HTG Molecular Diagnostics, Inc., RiboMed Biotechnologies, Inc., QIAGEN N.V. and NanoString Technologies, Inc.

GLOBAL CANCER PROFILING MARKET SEGMENTATION
By Technology
• Next generation sequencing (NGS)
o By region
• Quantitative polymerase chain reaction (QPCR)
o By region
• Immunohistochemistry (IHC)
o By region
• In-situ hybridization (ISH)
o By type
 Fluorescent in situ hybridization (FISH)
 Chromogenic in situ hybridization (CISH)
o By region
• Microarray
o By region
By Technique
• Genomics
o By region
• Proteomics
o By region
• Epigenetics
o By region
• Metabolomics
o By region
By Application
• Personalized medicine
o By region
• Diagnostics
o By region
• Biomarker discovery
o By region
• Prognostics
o By region
By Geography
North America
• By technology
• By technique
• By application
• By country - The U.S. and Canada
Europe
• By technology
• By technique
• By application
• By country - Germany, U.K., France, and Rest of Europe
Asia-Pacific
• By technology
• By technique
• By application
• By country - Japan, China, and Rest of Asia-Pacific
Latin America (LATAM)
• By technology
• By technique
• By application
• By country - Brazil, Mexico and Rest of LATAM
Middle East & Africa (MEA)
• By technology
• By technique
• By application

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.